For the first time, researchers have identified that an immune cell subset called gamma delta T cells that may be causing and/or perpetuating the systemic inflammation found in normal aging in the general geriatric population ...
Dec 11, 2018
0
665
HIV-infected patients remain on antiretroviral therapy for life because the virus survives over the long-term in infected dormant cells. Interruption of current types of antiretroviral therapy results in a rebound of the ...
Jul 8, 2015
0
49
New annual infections with HIV fell by 73 percent from its peak in the mid-1980s to 2019, according to a new analysis by US health authorities released Thursday.
Jun 4, 2021
0
10
In a special communication article published online Dec. 1 in the Journal of the American Medical Association, the International Antiviral Society-USA Panel presents updated recommendations for the use of antiretroviral drugs ...
Dec 9, 2022
0
15
For people living with HIV, sticking to a prescribed medication regimen is a critical part of staying healthy. However, having to deal with the side effects caused by those medications—nausea and dizziness among them—can ...
Nov 11, 2022
0
48
In the first results to emerge from HIV patient trials of a new generation of so-called broadly neutralizing antibodies, Rockefeller University researchers have found the experimental therapy can dramatically reduce the amount ...
Apr 8, 2015
0
38
Individuals with HIV who began taking antiretroviral therapy (ART) in the early stages of infection achieved a lengthy period of HIV suppression without ART after receiving two broadly neutralizing anti-HIV antibodies (bNAbs), ...
Jun 1, 2022
0
64
MitoQ, a mitochondrial antioxidant that is available to the public as a diet supplement, was found in a mouse study to reverse the detrimental effects that HIV and antiretroviral therapy (ART) have on mitochondria in the ...
Mar 24, 2023
0
10
Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. However, the mechanisms enabling this post-treatment ...
Aug 8, 2023
0
64
A Phase 1 clinical trial conducted by University of Minnesota researchers has demonstrated the safety and efficacy of a novel immunotherapy drug in the treatment of human immunodeficiency virus (HIV). Results of the trial ...
Feb 1, 2022
0
65
